中国神经再生研究(英文版) ›› 2026, Vol. 21 ›› Issue (9): 4051-4060.doi: 10.4103/NRR.NRR-D-25-00610

• 综述:神经损伤修复保护与再生 • 上一篇    下一篇

多组学技术:评估神经损伤与再生的新工具和方法

  

  • 出版日期:2026-09-15 发布日期:2026-05-16

Multi-omics technologies: Novel tools and methods for assessing nerve injury and regeneration

Qiang Zhou1, #, Zongren Zhao2, #, Da Tan1, Chenhao Fang1, Zhaoli Shen1, *, Shun Li3, *, Xianzhen Chen1, *   

  1. 1Department of Neurosurgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China; 
    2Department of Neurology, Ulm University, Ulm, Germany; 
    3Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • Online:2026-09-15 Published:2026-05-16
  • Contact: Xianzhen Chen, PhD, chenxianzheny@126.com; Shun Li, MD, lis24@upmc.edu; Zhaoli Shen, MS, leelies@sina.com.

摘要:

近年来,随着基因组学、转录组学、蛋白质组学和代谢组学等多组学技术的快速发展,神经损伤与再生研究领域涌现出诸多新型工具与方法。文章的目的是重点探讨多组学技术在揭示神经损伤机制、指导再生策略开发及促进临床转化方面的应用。通过整合多样化的组织学数据集,研究者能够全面追踪神经损伤后的动态分子变化,包括异常基因表达、蛋白质信号传导紊乱、代谢程序改变以及免疫微环境转变。单细胞多组学技术化解了细胞异质性难题,揭示了神经元、胶质细胞和免疫细胞亚群在损伤反应中的独特功能。空间分辨转录组学技术保留了病变与再生部位的空间关联性,为精准定位靶向干预提供了可能。多组学技术不仅能识别神经再生中的关键分子参与者,更创造了精准医疗的机遇。然而多组学数据整合面临高维度、批次效应及算法限制等技术挑战,干细胞疗法与基因编辑相关的伦理问题亦需严格监管。为实现从结构重建到功能重塑的跨越,未来研究应着力推进人工智能驱动的数据整合、芯片器官模型构建及跨学科协作,以突破现有技术壁垒,加速神经再生疗法的临床应用。


http://orcid.org/0000-0003-1915-4686 (Xianzhen Chen); 

http://orcid.org/0000-0001-8601-2261 (Shun Li); 

http://orcid.org/0000-0002-7376-6862 (Zhaoli Shen)

关键词: 人工智能, 生物标志物, 基因表达调控, 基因组学, 代谢组学, 神经再生, 神经通路, 蛋白质组学, 单细胞分析, 转录组学

Abstract: Recently, with the rapid advancement of multi-omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, new tools and approaches have been introduced for studying nerve injury and regeneration. This review highlights the application and progress of multi-omics in uncovering the mechanisms of nerve injury, guiding the development of regenerative strategies, and promoting clinical translation. By integrating multi-omics datasets, researchers can comprehensively track dynamic molecular changes following nerve injury, including abnormal gene expression, disrupted protein signaling, altered metabolic programs, and shifts in the immune microenvironment. Single-cell multi-omics technologies resolve cellular heterogeneity, revealing the distinct functions of neurons, glial cells, and immune cell subpopulations during the injury response. Spatially resolved transcriptomics maintain the spatial context of lesion and regeneration sites, enabling precise localization for targeted interventions. Multi-omics technologies not only identify key molecular players involved in nerve regeneration but also create opportunities for personalized medicine. Nonetheless, integrating multi-omics data poses technical challenges, including high dimensionality, batch effects, and algorithmic constraints, while ethical concerns related to stem cell therapy and gene editing require stringent oversight. To transition from structural reconstruction to functional remodeling, future research should emphasize artificial intelligence–driven data integration, organ-on-a-chip modeling, and cross-disciplinary collaboration to overcome existing technical barriers and accelerate the clinical application of neuroregenerative therapies. 

Key words: artificial intelligence, biomarkers, gene expression regulation, genomics, metabolomics, nerve regeneration, neural pathways, proteomics, single-cell analysis, transcriptomics